Ferra Joseph J Jr 4
4 · Elevation Oncology, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Ferra Joseph J Jr
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Common Stock
2025-03-16$0.53/sh−4,628$2,466→ 133,205 total - Exercise/Conversion
Common Stock
2025-03-16+12,562→ 137,833 total - Exercise/Conversion
Restricted Stock Unit
2025-03-16−12,562→ 12,560 total→ Common Stock (12,562 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on June 16, 2022, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.